Sefer Gezer to Middle Aged
This is a "connection" page, showing publications Sefer Gezer has written about Middle Aged.
Connection Strength
0.049
-
Hematologic genetic testing in high-risk patients before knee arthroplasty: a pilot study. Clin Orthop Relat Res. 2011 Jan; 469(1):131-7.
Score: 0.009
-
Idiopathic hemophagocytic syndrome with a fulminant clinical course. Clin Adv Hematol Oncol. 2008 Aug; 6(8):587-90.
Score: 0.007
-
Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression. Leuk Res. 2004 Aug; 28(8):791-803.
Score: 0.006
-
Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes. Leuk Res. 2001 Nov; 25(11):941-54.
Score: 0.005
-
High remission rate in acute myeloblastic leukemia with only two days of chemotherapy. Leuk Lymphoma. 2001 Apr; 41(3-4):333-6.
Score: 0.004
-
Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine). Leuk Res. 2000 Aug; 24(8):671-80.
Score: 0.004
-
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone. Blood. 2000 Mar 01; 95(5):1580-7.
Score: 0.004
-
Biologic characteristics of patients with hypocellular myelodysplastic syndromes. Leuk Res. 1999 Apr; 23(4):357-64.
Score: 0.004
-
Acute promyelocytic leukemia (APL) with an unusual cytogenetic presentation. Med Pediatr Oncol. 1998 Jan; 30(1):69-72.
Score: 0.004
-
Detection of BrdU in the regenerating bone marrow cells of a patient with AML. Leuk Res. 1989; 13(12):1055-9.
Score: 0.002